...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
【24h】

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.

机译:在浆液性积液中,卵巢癌细胞中的E-cadherin和α-,β-和γ-catenin蛋白表达上调。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aims of this study were firstly, to investigate the expression of E-cadherin complex proteins in ovarian carcinoma cells in serous effusions and in primary and metastatic lesions; and secondly to study the value of these four proteins and calretinin, a mesothelial marker, in the differential diagnosis of ovarian carcinoma cells from reactive mesothelial cells in effusions. Sixty-seven malignant effusions and 97 corresponding primary (n=36) and metastatic (n=61) lesions were immunohistochemically stained for E-cadherin and alpha-, beta-, and gamma-catenin. Staining extent and intensity were scored. Effusion specimens were additionally analysed for calretinin immunoreactivity. Membrane immunoreactivity for E-cadherin and alpha-, beta-, and gamma-catenin was detected on carcinoma cells in the majority of the effusions, but rarely on reactive mesothelial cells (p<0.001 for all markers). Calretinin immunoreactivity was confined to mesothelial cells (p<0.001). An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014). Up-regulation of all four cadherin complex proteins was seen in carcinoma cells in effusions, when compared with corresponding primary tumours (range p<0.001 to p=0.028). As with effusions, metastatic lesions showed up-regulation of alpha-, beta-, and gamma-catenin when compared with primary carcinomas (p=0.002-0. 015). Carcinoma cells in effusions showed in addition elevated levels of E-cadherin when compared with metastatic lesions (p<0.001). Staining results in effusions showed no association with effusion site, tumour type or histological grade. Immunoblotting on 29 malignant effusions confirmed the presence of all four proteins in the majority of samples and co-precipitation of E-cadherin and beta-catenin was seen in ten specimens examined. E-cadherin complex proteins are widely expressed in ovarian carcinoma cells. Together with calretinin, they form a powerful battery of markers for the cytological diagnosis of carcinoma cells in effusions. The up-regulation of E-cadherin complex proteins in serous effusions and metastatic lesions may mark an early metastatic phenotype and possibly mediates survival of tumour cells at these sites through the inhibition of apoptosis. Copyright 2000 John Wiley & Sons, Ltd.
机译:这项研究的目的是,首先,研究E-钙粘蛋白复合蛋白在浆液性积液以及原发性和转移性病变中在卵巢癌细胞中的表达;其次,研究这四种蛋白质和间皮标记物Calretinin在鉴别卵巢癌细胞与积液中反应性间皮细胞中的价值。对E-钙粘蛋白和α-,β-和γ-连环蛋白进行了免疫组织化学染色,对67例恶性积液和97个相应的原发性病变(n = 36)和转移性病变(n = 61)进行了染色。对染色程度和强度进行评分。另外对渗出样品的钙网蛋白免疫反应性进行分析。 E-钙粘蛋白和α-,β-和γ-连环蛋白的膜免疫反应在大多数积液中都在癌细胞上被检测到,但在反应性间皮细胞上却很少被检测到(对于所有标记而言,p <0.001)。 Calretinin的免疫反应性仅限于间皮细胞(p <0.001)。在积液和实体瘤中,E-钙粘蛋白和α-连环蛋白的表达之间存在关联,在实体瘤中,β-连环蛋白也存在关联(范围p <0.001至p = 0.014)。与相应的原发性肿瘤相比,渗出液中癌细胞中所有四个钙粘蛋白复合蛋白均表达上调(范围p <0.001至p = 0.028)。与积液一样,与原发癌相比,转移灶的α-,β-和γ-catenin表达上调(p = 0.002-0.015)。与转移性病变相比,积液​​中的癌细胞还显示E-钙黏着蛋白水平升高(p <0.001)。积液染色结果显示与积液部位,肿瘤类型或组织学分级无关。对29例恶性积液进行的免疫印迹证实,在大多数样品中都存在所有四种蛋白质,并且在所检查的十个样品中发现了E-钙粘蛋白和β-连环蛋白的共沉淀。 E-钙粘着蛋白复合蛋白在卵巢癌细胞中广泛表达。它们与钙黄绿素一起形成强大的标记物组,用于对积液中的癌细胞进行细胞学诊断。浆液性积液和转移性病变中E-钙粘蛋白复合蛋白的上调可能标志着早期转移表型,并可能通过抑制细胞凋亡介导了这些部位肿瘤细胞的存活。版权所有2000 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号